Page 4 - வெஸ்ட்பார்க் மூலதனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வெஸ்ட்பார்க் மூலதனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வெஸ்ட்பார்க் மூலதனம் Today - Breaking & Trending Today

Lixte Biotechnology Announces the Closing of $4.19 Million Registered Direct Offering

East Setauket, March 02, 2021 (GLOBE NEWSWIRE) Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs for use in cancer treatment, today announced that it has closed a registered direct offering with certain institutional and accredited investors for $4.19 million of common stock. The Company issued a total of 1,133,102 shares of common stock, at a purchase price of $3.70 per share. WestPark Capital, Inc. and WallachBeth Capital, LLC acted as co-placement agents for the offering. The gross proceeds to Lixte from this offering are expected to be approximately $4.19 million before deducting the placement agents’ fees and other offering expenses payable by Lixte. The company intends to use the net proceeds from the offering for working capital and general expenses including further development of its lead clinical compound LB-100. The shares of common stock were offered by Lixte pursuant to a "shel ....

The Company , Westpark Capital , Cancer Cells , Cancer Treatment , Cancer Research , Prospectus Supplement , தி நிறுவனம் , வெஸ்ட்பார்க் மூலதனம் , புற்றுநோய் செல்கள் , புற்றுநோய் சிகிச்சை , புற்றுநோய் ஆராய்ச்சி , ப்ரோஸ்பெக்டஸ் துணை ,